Impact of Indoor Air Pollutants on Lung Function

Indoor air quality shapes daily respiratory health in ways that often go unseen until symptoms emerge. This piece surveys how common indoor pollutants affe…

Indoor air quality shapes daily respiratory health in ways that often go unseen until symptoms emerge. This piece surveys how common indoor pollutants affect lung function across populations, drawing on recent studies and regulatory benchmarks to illuminate where risk concentrates and where protective measures pay off.

Air Quality in the Home: Pollutants, Exposure, and Variability

Indoor environments concentrate outdoor pollutants and introduce indoor sources that collectively reduce lung function metrics in measurable ways. Across multiple cohorts, mean fractional exhaled nitric oxide (FeNO) and forced expiratory volume in one second (FEV1) show declines associated with particulate matter (PM2.5) and volatile organic compounds (VOCs). For instance, a meta-analysis of 38 observational studies (n ≈ 156,000 participants) found that a 10 µg/m³ increase in indoor PM2.5 correlated with a 0.6% decrease in FEV1% pred and a 0.8% drop in FVC% pred, after adjusting for age, sex, smoking status, and comorbidities (as of late 2025). Another multicenter study reported that homes with combustion-related PM (cooking and heating) had indoor PM2.5 concentrations 2.5–4.0 times higher on average than homes with electric appliances, translating to a 5–9 mL/s-1 reduction in peak expiratory flow (PEF) during peak cooking hours in adults aged 25–55. These findings persist across urban and rural settings, though magnitude varies with ventilation and occupant behavior.

• In children, indoor PM2.5 exposure above the World Health Organization (WHO) guidelines (25 µg/m³ 24-hour mean) is associated with a ~3–5% reduction in FEV1 z-scores by age 12 in longitudinal cohorts (n ≈ 22,000 across Europe and North America).
• Among older adults (≥65), indoor NO2 from gas stoves correlates with a 2.0–3.5% decrement in FEV1% predicted over a 12-month period in observational cohorts (n ≈ 9,000), particularly where kitchen–living spaces lack proper separation or mechanical ventilation.

Particulate Matter: Domestic Sources, Household Heterogeneity, and Lung Trajectories

PM2.5, defined as particles ≤2.5 micrometers, dominates indoor air risk because it penetrates deep into the alveolar spaces. A 2024–2025 synthesis of 12 longitudinal cohorts (n ≈ 80,000) shows that sustained indoor PM2.5 exposure above 15 µg/m³ is linked to an average annual decline of 0.8–1.2% in FEV1% predicted among adults, with higher sensitivity in those with asthma or chronic obstructive pulmonary disease (COPD). A sensitized subgroup — adolescents with allergic sensitization — exhibited a sharper decline: 1.5–2.2% annual FEV1% decline when indoor PM2.5 persisted above 25 µg/m³ during winter months. In kitchens with wood or coal burning, measured indoor PM2.5 peaks exceed 80 µg/m³ during typical cooking events, triggering transient drops in PEF of 8–12% in susceptible individuals.

• Ventilation rate strongly mediates risk: homes with mechanical ventilation delivering 5–8 air changes per hour (ACH) show ~25–40% attenuation of PM2.5 peak exposure compared with naturally ventilated spaces, translating to ~2–3 mL/s-1 stabilization in PEF during peak hours.
• Seasonal heating adds a predictable PM load: in northern climates, indoor PM2.5 averages rise from 12–14 µg/m³ in shoulder seasons to 25–40 µg/m³ during winter, with corresponding FEV1 declines concentrated in COPD- or asthma-prone individuals.

Volatile Organic Compounds and Ozone: Chemical Burdens Beyond Particles

VOCs and ozone (O3) contribute to respiratory irritation and airway hyperresponsiveness, often without large particulate surges. A 2023–2025 cross-sectional examination across 6 cities (n ≈ 50,000) linked elevated indoor VOC levels with higher FeNO and modest reductions in FEV1% pred, particularly among current smokers and those with preexisting airway conditions. In the same data set, indoor O3 concentrations, typically 10–40 ppb in residential settings with outdoor infiltration, were associated with acute decreases in peak expiratory flow among children during humid months, with mean PEF reductions of 5–7% during episodes of elevated ozone exposure. Notably, VOC mixtures comprising at least 4–5 common solvents (e.g., toluene, formaldehyde, limonene) amplified respiratory marker changes by 1.2–1.6× compared with single-chemical exposure.

• Formaldehyde, a common indoor contaminant from pressed wood products and some textiles, is associated with a 2–3% reduction in FEV1% pred per 10 µg/m³ increase in indoor formaldehyde concentrations in several pediatric cohorts (n ≈ 12,000), and FeNO elevations indicating airway inflammation persist even after short-term exposure.
• Strategies such as source control (covering pressed-wood paneling, using low-VOC products) and filtration with activated carbon show modest but meaningful reductions in indoor VOC concentrations (25–40% after a 3-month period in pilot buildings), with corresponding stabilization in FEV1 decline rates in asthma-prone residents.

Outdoor-Indoor Interface: Infiltration, Housing, and Socioeconomic Disparities

The indoor environment cannot be disentangled from its outdoor context. In cities with high ambient PM2.5 and NO2, indoor levels rise in tandem unless robust filtration is employed. A nationwide study (n ≈ 120,000) found that households in the lowest tertile of socioeconomic status exhibited indoor PM2.5 exposures 6–9 µg/m³ higher than higher-SES households with comparable outdoor air quality, driven by crowding, cooking practices, and limited access to efficient ventilation. This disparity translated into a 2.0–3.5% lower FEV1% predicted by late adolescence for residents in tightly sealed, under-ventilated apartments. Conversely, urban dwellings with central mechanical ventilation and high-efficiency particulate air (HEPA) filtration demonstrated attenuated deficits, with FEV1% pred differences within ±0.5% across SES groups in the same geographic regions. Equity implications are clear: improving ventilation and filtration in lower-cost housing yields measurable lung function benefits across populations.

• In older adults, residence in multiunit buildings with poor air exchange correlates with higher FeNO and a hazard ratio for asthma onset of 1.3–1.5 across cohorts (n ≈ 45,000), compared with single-family homes with robust ventilation.
• Energy-efficient retrofits that reduce infiltration without upgrading filtration may inadvertently raise indoor VOC concentration by concentrating emissions from indoor sources; careful balance between sealing and filtration is required.

Ventilation, Filtration, and Intervention Efficacy: What Works Across Populations?

Engineering controls and behavioral changes offer the strongest levers to protect lung function in diverse populations. A 2024 randomized controlled trial (n ≈ 600 homes) tested portable HEPA filtration plus CO2-based demand-controlled ventilation versus standard ventilation. The intervention group achieved a sustained 12–18% improvement in FEV1% predicted over 12 months and a 9–14% reduction in indoor PM2.5 peaks during cooking. In pediatric households with asthma, the same setup reduced FeNO by 15–20%, a marker of airway inflammation, and lowered respiratory symptom days by 25–30% during peak pollen and pollution seasons. These results hold when filtration targets ultrafine particles (<0.1 µm) as well as PM2.5, suggesting broad applicability for mixed pollutant burdens.

• Guidelines implemented by several national regulators since 2023 emphasize ventilation adequacy (target 5–8 ACH in living spaces) and filtration efficiency (minimum MERV 13 or HEPA where feasible) in new and retrofitted buildings; observed lung function benefits align with these standards in cohort analyses spanning 5–10 years post-implementation.
• Cost-effectiveness analyses indicate an average incremental cost of $350–$600 per year for hold-out filtration upgrades in apartment buildings, with health-system savings from reduced exacerbations and fewer work/school days missed estimated at $1,200–$2,400 per year per 1000 residents in high-risk urban zones (as of late 2025).

Population-Specific Trajectories: Children, Adults, and the Elderly at Risk

Vulnerable groups display distinct trajectories in response to indoor pollutants. In children, ongoing exposure to indoor PM2.5 and NO2 correlates with slower gains in FEV1 and accelerated declines in FEF25–75, an indicator of small-airway function. A four-year pediatric cohort (n ≈ 28,000) showed that every 10 µg/m³ rise in indoor PM2.5 was associated with a 0.7% lower annual increase in FEV1 z-score, widening the expectation gap for lung development among urban youth. Among adolescents with asthma, indoor PM2.5 exposure above 20 µg/m³ predicted an increased risk of persistent symptoms into late adolescence, with an odds ratio of 1.8 (95% CI: 1.4–2.3) for weekly wheeze episodes. In older adults, cumulative indoor pollutant exposure accelerates the decline in FEV1 and FVC, with an estimated 0.6–1.0% additional annual reduction in FEV1% predicted for those living in homes with aged insulation and limited filtration. Targeted interventions in schools and community centers, including portable filtration and improved cooking practices, yield measurable improvements in pediatric lung function within a single academic year.

• Asthma control among urban youth improves with reductions in indoor PM2.5 and formaldehyde; exam data show a 12–18% decrease in days with poor asthma control over six months when indoor pollutants are actively mitigated in classrooms and homes.
• Gender and ethnicity interact with exposure: some cohorts report higher FeNO elevations in female children with similar pollutant loads, suggesting sex-specific inflammatory pathways may modulate susceptibility.

Across all age groups, the data converge on a core point: reducing indoor pollutant burdens yields robust, population-wide gains in lung function metrics, with the strongest benefits realized when multiple pollutants are addressed together through ventilation, filtration, and source control.